CD8+ T cell responses directed against multiple pathogen-derived epitopes are characterized by defined immunodominance hierarchy patterns. A possible explanation for this phenomenon is that CD8+ T cells of different specificities compete for access to epitopes on antigen-presenting cells, and that the outcome of this so-called cross-competition reflects the number of induced T cells. In our study using a vaccinia virus infection model, we found that T cell cross-competition is highly relevant during boost vaccination, thereby shaping the immunodominance hierarchy in the recall. We demonstrate that competition was of no importance during priming and was unaffected by the applied route of immunization. It strongly depended on the timing of viral antigen expression in infected APCs, and it was characterized by poor proliferation of T cells recognizing epitopes derived from late viral proteins. To our knowledge, this is the first demonstration of the functional importance of T cell cross-competition during a viral infection. Our findings provide a basis for novel strategies for how boost vaccination to defined antigens can be selectively improved. They give important new insights into the design of more efficient poxviral vectors for immunotherapy.
Skip Nav Destination
Article navigation
3 September 2007
Article|
August 20 2007
Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination
Wolfgang Kastenmuller,
Wolfgang Kastenmuller
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
4Institute of Virology, Technical University Munich, 81675 Munich, Germany
Search for other works by this author on:
Georg Gasteiger,
Georg Gasteiger
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
Search for other works by this author on:
Julian H. Gronau,
Julian H. Gronau
1Institute of Molecular Virology
Search for other works by this author on:
Robert Baier,
Robert Baier
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
Search for other works by this author on:
Ronny Ljapoci,
Ronny Ljapoci
1Institute of Molecular Virology
Search for other works by this author on:
Dirk H. Busch,
Dirk H. Busch
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
5Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, 81675 Munich, Germany
Search for other works by this author on:
Ingo Drexler
Ingo Drexler
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
Search for other works by this author on:
Wolfgang Kastenmuller
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
4Institute of Virology, Technical University Munich, 81675 Munich, Germany
Georg Gasteiger
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
Julian H. Gronau
1Institute of Molecular Virology
Robert Baier
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
Ronny Ljapoci
1Institute of Molecular Virology
Dirk H. Busch
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
5Institute for Medical Microbiology, Immunology and Hygiene, Technical University Munich, 81675 Munich, Germany
Ingo Drexler
1Institute of Molecular Virology
2Antigen-specific Immunotherapy Clinical Cooperation Group,
3Immune Monitoring Clinical Cooperation Group, National Research Center for Environment and Health, 81675 Munich, Germany
CORRESPONDENCE Ingo Drexler:[email protected]
Abbreviations used: CEF, chicken embryo fibroblast; CVA, chorioallantois VV Ankara; IU, infectious unit; LCMV, lymphocytic choriomeningitis virus; MOI, multiplicity of infection; MVA, modified VV Ankara; VV, vaccinia virus.
W. Kastenmuller and G. Gasteiger contributed equally to this paper.
Received:
March 09 2007
Accepted:
July 19 2007
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2007
J Exp Med (2007) 204 (9): 2187–2198.
Article history
Received:
March 09 2007
Accepted:
July 19 2007
Citation
Wolfgang Kastenmuller, Georg Gasteiger, Julian H. Gronau, Robert Baier, Ronny Ljapoci, Dirk H. Busch, Ingo Drexler; Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination . J Exp Med 3 September 2007; 204 (9): 2187–2198. doi: https://doi.org/10.1084/jem.20070489
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement